The Partnership Architecture
Abbott and Google have entered a multiyear agreement that represents one of the most significant integrations of continuous glucose monitoring (CGM) technology with artificial intelligence-powered health coaching to date. The collaboration will feed data from Abbott’s Lingo continuous glucose monitor directly into the Google Health app, where Google’s Gemini-powered Health Coach will synthesize glucose trends with activity, sleep, and other wellness metrics to generate personalized recommendations.
Users will need a Google Health Premium subscription to access the AI coach functionality. The companies expect the Lingo integration to begin rolling out in the Google Health app later this year, according to the announcement.
Under a multiyear agreement, data from Abbott’s Lingo continuous glucose monitor will be integrated into the Google Health app. Users will be able to view glucose trends alongside information related to activity, sleep, and other wellness metrics.
Understanding the Lingo Technology
The Lingo system represents Abbott’s strategic expansion beyond traditional diabetes management into the broader consumer wellness market. Unlike Abbott’s FreeStyle Libre platform, which is cleared for diabetes management, Lingo is an over-the-counter continuous glucose monitoring system designed specifically for adults aged 18 and older who do not use insulin.
According to FDA documentation, Lingo operates through a sensor inserted under the skin on the back of the upper arm. The device continuously measures glucose in interstitial fluid rather than directly from blood, using an electrochemical process before transmitting readings to the Lingo app via Bluetooth Low Energy. Each sensor can be worn for up to 14 days.
Key Technical Specifications
- Continuous measurement of glucose in interstitial fluid
- Bluetooth Low Energy transmission to companion app
- 14-day sensor wear time
- Real-time glucose values, trend arrows, and glucose graphs
- No glucose or system alerts provided by the app
The FDA describes Lingo as a system for helping adults who do not use insulin understand how glucose readings relate to nutrition, exercise, and daily activities. FDA documentation explicitly states that users should not take medical action based on Lingo readings without consulting a qualified healthcare professional.
Abbott made Lingo available without a prescription in the US in 2024, and the system is also available in the UK. The product is built on technology used in Abbott’s FreeStyle Libre platform, though with a distinctly different intended use case focused on wellness optimization rather than disease management.
Google’s Expanding Health Data Ecosystem
The Abbott integration builds upon Google’s broader strategy to position the Google Health app as a central hub for personal health information. The company has been systematically expanding the types of data available to Health Coach, creating an increasingly comprehensive picture of user health.
In May, Google announced that US users could sync medical records with the Google Health app, including laboratory results, vital signs, and medication information. Users can share those records with the AI coach to ask questions or receive summaries. The app can also receive information from compatible wearables and third-party applications through Health Connect, Apple Health, and Google Health APIs.
Data Sources Connected to Google Health Coach
- Activity, fitness, and sleep data from wearables
- Vital signs from compatible devices
- Medical records including laboratory results and medication information
- Third-party applications through Health Connect and Apple Health
- Continuous glucose data from Abbott Lingo (forthcoming)
Google states that users maintain control over their health information, with options to decide what information to save, turn optional features on or off, export data, and delete it. The company also states that Google Health data is not used for Google Ads.
The AI Coaching Model and Its Limitations
Google Health Coach, built with Gemini, represents a significant bet on AI-driven personalized health recommendations. The system is designed to provide recommendations covering nutrition, activity, sleep, and recovery by synthesizing multiple data streams, including the forthcoming glucose data from Lingo.
However, Google has been explicit about the limitations of the technology. The company says Health Coach is not intended for medical purposes and warns that its AI responses can be inaccurate or incomplete. Google advises users to verify its responses and consult healthcare professionals when appropriate.
Google says Health Coach is not intended for medical purposes and warns that its AI responses can be inaccurate or incomplete. The company advises users to verify its responses and consult healthcare professionals when appropriate.
This positioning reflects the broader challenge of bringing AI into consumer health applications: the technology must be useful enough to justify its existence while maintaining clear boundaries around medical claims and maintaining appropriate caution about AI-generated recommendations.
Research Partnership and Future Development
Beyond the commercial integration, Abbott and Google are planning a large real-world study focused on metabolic health. The research will combine continuous glucose readings with wearable, laboratory, and survey data to examine relationships between activity, sleep, well-being, and metabolic health.
The companies stated that findings from this study will be used to refine Google Health Coach and inform future Lingo features, suggesting a feedback loop between research insights and product development that could accelerate the sophistication of AI-driven health recommendations over time.
Broader Context: Gemini’s Healthcare Expansion
The Abbott partnership is part of a broader pattern of Google extending Gemini into healthcare-related tasks. Also this week, Zocdoc announced that US users can search for healthcare appointments and book providers directly through the Gemini app.
The Zocdoc connected app provides real-time appointment availability from a network of more than 200,000 providers across more than 200 specialties. Zocdoc noted it is Gemini’s first connected-app partner for health appointments, signaling Google’s intent to make Gemini a gateway for multiple healthcare interactions.
Implications for the Consumer Health Technology Landscape
The integration raises significant questions about the evolving relationship between consumer health technology and traditional medical oversight. While Lingo is explicitly positioned as a wellness tool rather than a medical device, the continuous glucose data it provides has traditionally been the domain of diabetes management under medical supervision.
The combination of CGM data with AI-powered recommendations represents a new frontier in personalized wellness technology. Users will receive AI-generated advice informed by granular physiological data that was previously available primarily to those managing diagnosed medical conditions. This democratization of health data carries both opportunities for improved wellness outcomes and risks related to interpretation and action without professional guidance.
The explicit warnings from both Google and FDA documentation about not taking medical action based on these tools without consulting healthcare professionals highlights the delicate balance these companies must strike between empowering consumers with information and maintaining appropriate medical boundaries.